Previous Post
Resuscitation Therapeutics (RTx) – an early-stage company focused on developing new therapies for life-threatening acute cardiovascular events – is preparing an Investigational New Drug (IND) application for submission to the U.S. Food and Drug Administration ... Read More
Next Post
Lake County-headquartered Nexus Pharmaceuticals has received FDA Approval for its innovative Tirofiban Hydrochloride Injection, designed to reduce the rate of certain cardiovascular events. This is a big milestone for the US-based, woman-led, minority-owned healthcare company ... Read More